LexDanaLexDanabeta
Inventor

Juha Punnonen

Inventor
Belmont, CA, US

Overview

26→
Patents
2003–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes16%
C12NMicroorganisms or enzymes12%
Y02ATechnologies for adaptation to climate change11%
C07DHeterocyclic compounds5%
C40BCombinatorial chemistry5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology1%
PatentTitleYear
9,657,024'Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival'20179,186,397'Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein'20159,163,027'Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival'20158,715,694'Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein'20148,496,935'Immunosuppressive polypeptides and nucleic acids'20138,491,899'Immunosuppressive polypeptides and nucleic acids'20138,445,230'Immunosuppressive polypeptides and nucleic acids'20138,318,176'Immunosuppressive polypeptides and nucleic acids'20128,283,447'Immunosuppressive polypeptides and nucleic acids'20128,268,587'Immunosuppressive polypeptides and nucleic acids'20128,168,772'Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling'20128,158,131'Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein'20128,143,287'Thrombopoietin mimetics'20128,071,095'Immunosuppressive polypeptides and nucleic acids'20117,794,718'Immunosuppressive polypeptides and nucleic acids'20107,786,159'Thrombopoietin mimetics'20107,612,170'Co-stimulatory polypeptides'20097,476,390'Flavivirus antigens'20097,390,619'Optimization of immunomodulatory properties of genetic vaccines'20087,183,376'Variant B7 co-stimulatory molecules'20077,115,712'Cytokine polypeptides'20067,094,875'Co-stimulatory polypeptides'20067,074,590'Chimeric promoters'20066,576,757'Polynucleotides encoding flavivirus and alphavirus multivalent antigenic polypeptides'20036,569,435'Flavivirus and alphavirus recombinant antigen libraries'20036,541,011'Antigen library immunization'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2009Patents assigned to MAXYGEN INC (10)· patent assignee history
2003–2006Based in Palo Alto, CA, US· patent location history
2006–2017Based in Belmont, CA, US· patent location history
2010–2013Patents assigned to PERSEID THERAPEUTICS LLC (8)· patent assignee history
2011–2014Patents assigned to PUNNONEN JUHA (11)· patent assignee history
2011–2013Patents assigned to BASS STEVEN H (7)· patent assignee history
2011–2013Patents assigned to CHAPIN STEVEN J (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PUNNONEN JUHAself112011–2014
MAXYGEN INC102003–2009
PERSEID THERAPEUTICS LLC82010–2013
BASS STEVEN H72011–2013
CHAPIN STEVEN J72011–2013
Locations
LocationPatentsSpan
Belmont, California, US222006–2017
Palo Alto, California, US42003–2006